Diabetes Discourse by ReachMD
ReachMD
As the number of Americans living with diabetes continues to rise, staying up to date on the latest diabetes research is more essential than ever to help patients achieve glucose control. With Diabetes Discourse, you’ll hear from diabetes and endocrinology experts on emerging research, diagnostic and treatment strategies, and various elements that impact a patient’s disease course, including risk factors, vitamin and mineral supplementation, physical activity, and kidney disease. Because when it comes to diabetes, glucose control is just the beginning.
Categories: Science & Medicine
Listen to the last episode:
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Ian de Boer, MD
Since up to 40 percent of patients with diabetes develop diabetic kidney disease, it’s essential to know how to proactively diagnose and treat them using the latest therapeutic advances and strategies. Tune in to hear Dr. Mary Katherine Cheeley discuss diabetes management in patients with chronic kidney disease with Dr. Ian de Boer, Professor of Medicine in the Division of Nephrology and the Director of the Kidney Research Institute at the University of Washington in Seattle.
Previous episodes
-
604 - Diabetes and CKD: Strategies for Diagnosis and TreatmentTue, 21 May 2024
-
603 - Uncovering the Prevalence of Type 1 Diabetes in Older AdultsThu, 09 May 2024
-
602 - Concentrating on the MOMPOD Trial for Metformin Plus InsulinFri, 12 Apr 2024
-
601 - Utilizing Hybrid Closed-Loop Technology for T1D Pediatric PatientsTue, 09 Apr 2024
-
600 - Semaglutide Reduces CV Events in Non-Diabetic, Overweight PatientsMon, 08 Apr 2024
-
599 - Overcoming Obesity: Insights from the SURMOUNT-4 TrialWed, 27 Mar 2024
-
598 - Strategies for Addressing Diabetes Stigma and DiscriminationThu, 01 Feb 2024
-
597 - How the Artificial Pancreas Can Help Diabetic PatientsWed, 20 Dec 2023
-
596 - Using CGMs and Insulin Pumps to Treat Pediatric Patients with T1DTue, 19 Dec 2023
-
595 - Challenging the Misconception That T1D Is a Childhood-Onset DiseaseTue, 05 Dec 2023
-
594 - Decoding Diabetes Diversity: A Study on Heterogeneity and Endotypes in T1DMon, 04 Dec 2023
-
593 - Why Hybrid Closed-Loop Insulin Therapy Should Be Offered to Pregnant T1D PatientsMon, 27 Nov 2023
-
592 - Discussing a T2D Medication That Could Reduce Insulin Needs in T1DMon, 27 Nov 2023
-
591 - How Overnight Glucose Levels Impact Daily Activities in T1D PatientsFri, 10 Nov 2023
-
590 - Breaking Down Biosimilar Insulins: A Look at the Regulatory Process and ImpactsWed, 25 Oct 2023
-
589 - Educating Providers and Patients About Insulin BiosimilarsMon, 23 Oct 2023
-
588 - How Ultra-Processed Foods Increase the Risk of Type 2 DiabetesFri, 20 Oct 2023
-
587 - Recapping a Narrative Review on the Management of Chronic Kidney Disease in T2DTue, 26 Sep 2023
-
586 - The Impact of RADIANT: A Deep Dive into the StudyWed, 20 Sep 2023
-
585 - Guiding Principles of Treating Gestational DiabetesMon, 18 Sep 2023
-
584 - How Diet Can Affect the Gut MicrobiomeThu, 03 Aug 2023
-
582 - Key Considerations for CGM Use in Older Adults with T1DWed, 19 Jul 2023
-
581 - Vitamin D Can Reduce the Risk of T2D in Prediabetic PatientsFri, 02 Jun 2023
-
580 - How Hypoglycemia Can Lead to Unsafe Driving Practices in T1D PatientsThu, 01 Jun 2023
-
579 - Fad Diets & Patients with Type 2 DiabetesMon, 18 Jan 2021
-
578 - Investigating the Impact of Bempedoic Acid on Cardiovascular Outcomes in Statin-Intolerant PatientsTue, 16 May 2023
-
577 - Addressing Gaps to Tackle Obesity in Patients with Type 1 DiabetesMon, 08 May 2023
-
576 - Closing Gaps in Care for Patients with T2D & CV DiseaseTue, 28 Mar 2023
-
575 - Maximizing Weight Loss & Minimizing Side Effects With GLP-1Tue, 28 Mar 2023
-
574 - Adapting Our Exercise Talk: Key Tips on Counseling Patients on ExerciseThu, 02 Mar 2023
-
573 - Insights from Obesity Canada: A Deep Dive into Guideline UpdatesThu, 26 Jan 2023
-
572 - Key Therapeutic Insights on Semaglutide in Adolescent ObesityMon, 23 Jan 2023
-
571 - Explore Impacts Of Glucose-Lowering Medications in Addition to MetforminTue, 20 Dec 2022
-
570 - Key Insights from GRADE: Exploring Data on Glycemia Reduction in T2DMon, 12 Dec 2022
-
569 - Breaking Down the Bionic Pancreas: A Device for Dosing Decisions for T1DMon, 07 Nov 2022
-
568 - An Assessment of Automated Insulin Delivery Systems for T1DFri, 04 Nov 2022
-
567 - A Look at Comprehensive Telehealth for PPDMFri, 28 Oct 2022
-
566 - SNAP, Food Insecurity, & Healthcare Spending: What Do We Need to Know?Fri, 28 Oct 2022
-
565 - Getting to Know GRADE: A Comparative Study of T2D TreatmentTue, 25 Oct 2022
-
564 - Exploring Precision Medicine in the Treatment of DiabetesMon, 24 Oct 2022
-
563 - Can Generic Drugs Be Repurposed for COVID-19 Treatment?Mon, 24 Oct 2022
-
559 - A Fight Against Obesity: Evaluating Clinical Data from the SURMOUNT-1 TrialWed, 17 Aug 2022
-
558 - Heart Failure Consensus Report: A Review of ADA RecommendationsTue, 16 Aug 2022
-
557 - Exploring AACE Updates on the Management of NAFLD & NASHThu, 11 Aug 2022
-
556 - The IRIS Trial: Reviewing Results & Taking a Look at PioglitazoneThu, 11 Aug 2022
-
555 - Investigating Interventions: The Role of Lifestyle Changes in Preventing DiabetesFri, 20 May 2022
-
554 - Exploring A New Anti-Obesity TreatmentThu, 12 May 2022
-
553 - Exploring the Deintensification of Hypoglycemia-Inducing MedicationsThu, 21 Apr 2022
-
551 - Investigating the T1D Increase: A Look at Rising Rates in Children Amid COVID-19Mon, 11 Apr 2022
-
550 - Evaluating the Rapid Rise of T1D in Children Amid the COVID-19 PandemicMon, 11 Apr 2022
